Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DB25FWZ30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,109
Award facts
- Contract value 100% obligated
- $4,109.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,109.19 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml auto-injector pens. This firm fixed-price, non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of competitively awarded delivery orders through the Defense Logistics Agency. The company's contracts support multiple therapeutic domains and serve various government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This award of Actemra Actpen—a rheumatoid arthritis and other inflammatory condition treatment—demonstrates the company's role in supplying specialized pharmaceutical commodities to support military healthcare needs through the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FWZ30?
SPE2DB25FWZ30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FWZ30 worth?
The government has obligated $4,109 on SPE2DB25FWZ30.
Is contract SPE2DB25FWZ30 an order under another contract?
Yes. SPE2DB25FWZ30 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWZ30 competed?
The extent of competition for SPE2DB25FWZ30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award